Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Deep Brain Stimulation in Parkinson’s Disease Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neurological diseases
5.1.1.2. Rapidly aging population, leading to risk and high prevalence of neurological disorders
5.1.1.3. Rising popularity of minimally invasive procedures
5.1.2. Restraints
5.1.2.1. Complex regulatory framework
5.1.3. Opportunities
5.1.3.1. Increasing technological advancement in devices
5.1.3.2. Surge in neurological R&D
5.1.4. Challenges
5.1.4.1. Complications of deep brain stimulation surgery
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Deep Brain Stimulation in Parkinson’s Disease Market, by Product
6.1. Introduction
6.2. Dual Channel
6.3. Single Channel

7. Deep Brain Stimulation in Parkinson’s Disease Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Hospitals
7.4. Neurology Clinics
7.5. Research Centers

8. Americas Deep Brain Stimulation in Parkinson’s Disease Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Aleva Neurotherapeutics SA
12.1.3. Beijing Pins Medical Co.,Ltd.
12.1.4. Boston Scientific Corporation
12.1.5. Functional Neuromodulation Ltd.
12.1.6. General Electric Co.
12.1.7. Medtronic PLC
12.1.8. MicroTransponder Inc.
12.1.9. Neuronetics Inc.
12.1.10. NeuroPace Inc.
12.1.11. NeuroSigma, Inc.
12.1.12. Nexstim Oy
12.1.13. Renishaw PLC
12.1.14. Siemens AG
12.1.15. St. Jude Medical, Inc.
12.1.16. Synapse Biomedical Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET RESEARCH PROCESS
FIGURE 2. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET DYNAMICS
FIGURE 7. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 9. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. CHINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. CHINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. INDIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. INDIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. JAPAN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. JAPAN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. THAILAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. THAILAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. EGYPT DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. EGYPT DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. NORWAY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. NORWAY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. POLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. POLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TURKEY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TURKEY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 100. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 101. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET LICENSE & PRICING